Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

IPO
Biotech

Iambic goes public with $150M IPO to accelerate cancer pipeline

Iambic Therapeutics’ IPO hit its target, bringing in $150 million for the AI biotech to fuel the clinical development of its oncology pipeline.
James Waldron Oct 15, 2026 2:30am
Monumental Sports Entertainment Vanda Pharmaceuticals studio

Vanda pauses social anxiety program after failing phase 3 trial

Oct 15, 2026 2:25am
iRegene Therapeuticss NouvSight001 Cleared for Clinical Trials in the US and China for Retinitis Pigmentosa

iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

Brought to you by iRegene Therapeutics
OMass CEO Ros Deegan

OMass’ $310M raise fuels goal to become ‘Britain’s Big Biotech’

Oct 15, 2026 2:00am
video
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
close-up image of an eye

Merck KGaA spinout iOnctura touts PI3K inhibitor in eye cancer

Oct 14, 2026 1:42pm